NCT05488457View on ClinicalTrials.gov

Oxytocin Pharmacokinetics and Pharmacodynamics

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2027

Conditions
Post Partum HemorrhageCesarean Section ComplicationsBlood Loss
Interventions
DRUG

deuterated oxytocin (d5OT)

Subjects will receive a 1 IU bolus of deuterated oxytocin (d5OT) intraoperatively during their nonemergent cesarean delivery.

Trial Locations (2)

60637

RECRUITING

University of Chicago, Chicago

94305

NOT_YET_RECRUITING

Stanford University, Stanford

All Listed Sponsors
collaborator

Stanford University

OTHER

lead

University of Chicago

OTHER